|
| 37852366 | Current Transthoracic Supra-Aortic Trunk Surgical Reconstruction Has Similar 30-Day Cardiovascular Outcomes Compared to Extra-Anatomic Revascularization but With Higher Morbidity Burden. | Ann Vasc Surg | 2024 |
| 37505352 | Implementation of a Novel Patient Decision Aid for Women with Elevated Breast Cancer Risk Who Are Considering MRI Screening: A Pilot Study. | Ann Surg Oncol | 2023 |
| 33689923 | Prediction of Prolonged Intensive Care Unit Length of Stay Following Cardiac Surgery. | Semin Thorac Cardiovasc Surg | 2022 |
| 36278434 | Somatic mutations show no clear association with red blood cell or human leukocyte antigen alloimmunization in de novo or therapy-related myelodysplastic syndrome. | Transfusion | 2022 |
| 36067239 | A Decision Aid for Patients With Minimally Suspicious Screening Mammograms: A Pilot Study. | Oncol Nurs Forum | 2022 |
| 33479025 | Trial to evaluate the immunogenicity and safety of a melanoma helper peptide vaccine plus incomplete Freund's adjuvant, cyclophosphamide, and polyICLC (Mel63). | J Immunother Cancer | 2021 |
| 34624059 | Disparities in telemedicine utilization among surgical patients during COVID-19. | PLoS One | 2021 |
| 34413169 | Phase I/II trial of a long peptide vaccine (LPV7) plus toll-like receptor (TLR) agonists with or without incomplete Freund's adjuvant (IFA) for resected high-risk melanoma. | J Immunother Cancer | 2021 |
| 34175585 | Determining the Association Between Unplanned Reoperation and Readmission in Selected General Surgery Operations. | J Surg Res | 2021 |
| 34035112 | Immunogenicity in humans of a transdermal multipeptide melanoma vaccine administered with or without a TLR7 agonist. | J Immunother Cancer | 2021 |
| 33948862 | Specialty-Specific Readmission Risk Models Outperform General Models in Estimating Hepatopancreatobiliary Surgery Readmission Risk. | J Gastrointest Surg | 2021 |
| 33454795 | Characterization and comparison of innate and adaptive immune responses at vaccine sites in melanoma vaccine clinical trials. | Cancer Immunol Immunother | 2021 |
| 33361259 | Risk of Venous Thromboembolism in Grade II-IV Gliomas as a Function of Molecular Subtype. | Neurology | 2021 |
| 32385144 | MHC-restricted phosphopeptide antigens: preclinical validation and first-in-humans clinical trial in participants with high-risk melanoma. | J Immunother Cancer | 2020 |
| 33664968 | Predictors of early, recurrent, and intractable seizures in low-grade glioma. | Neurooncol Pract | 2020 |
| 31983407 | The impact of cirrhosis and MELD score on postoperative morbidity and mortality among patients selected for liver resection. | Am J Surg | 2020 |
| 32765523 | IgG Subclass Determines Suppression Versus Enhancement of Humoral Alloimmunity to Kell RBC Antigens in Mice. | Front Immunol | 2020 |
| 30891689 | Functional and Cognitive Status in Clostridium difficile Infection in the Hospitalized Elderly: a Retrospective Study of Two Sites. | J Gen Intern Med | 2019 |
| 31175168 | Lower volume, more impairment: reduced cholinergic basal forebrain grey matter density is associated with impaired cognition in Parkinson disease. | J Neurol Neurosurg Psychiatry | 2019 |
| 31248461 | A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund's adjuvant in melanoma patients. | J Immunother Cancer | 2019 |
| 29668917 | Nonadherence to Biologic Therapies in Inflammatory Bowel Disease. | Inflamm Bowel Dis | 2018 |
| 29969606 | PD-L1 expression in tumor cells and the immunologic milieu of bladder carcinomas: a pathologic review of 165 cases. | Hum Pathol | 2018 |
| 29618627 | Baseline symptoms and basal forebrain volume predict future psychosis in early Parkinson disease. | Neurology | 2018 |
| 27919761 | More than Just the Number of Brain Metastases: Evaluating the Impact of Brain Metastasis Location and Relative Volume on Overall Survival After Stereotactic Radiosurgery. | World Neurosurg | 2017 |
| 29157306 | A pilot study of the immunogenicity of a 9-peptide breast cancer vaccine plus poly-ICLC in early stage breast cancer. | J Immunother Cancer | 2017 |
| 28735797 | Characteristics, correlates, and assessment of psychosis in Parkinson disease without dementia. | Parkinsonism Relat Disord | 2017 |
| 26864349 | Prognostic value of albumin in patients with head and neck cancer. | Laryngoscope | 2016 |
| 26581199 | A randomized pilot trial testing the safety and immunologic effects of a MAGE-A3 protein plus AS15 immunostimulant administered into muscle or into dermal/subcutaneous sites. | Cancer Immunol Immunother | 2016 |
| 27999753 | PD-L1, PD-L2 and PD-1 expression in metastatic melanoma: Correlation with tumor-infiltrating immune cells and clinical outcome. | Oncoimmunology | 2016 |
| 27143519 | Orbital Metastases from Breast Cancer: Retrospective Analysis at an Academic Cancer Center. | Breast J | 2016 |
| 27522582 | Topical treatment of melanoma metastases with imiquimod, plus administration of a cancer vaccine, promotes immune signatures in the metastases. | Cancer Immunol Immunother | 2016 |
| 27522581 | Intratumoral interferon-gamma increases chemokine production but fails to increase T cell infiltration of human melanoma metastases. | Cancer Immunol Immunother | 2016 |
| 27511846 | A Novel Form of Breast Intraoperative Radiation Therapy With CT-Guided High-Dose-Rate Brachytherapy: Results of a Prospective Phase 1 Clinical Trial. | Int J Radiat Oncol Biol Phys | 2016 |
| 25124183 | Impact of blood transfusions on patients with head and neck cancer undergoing free tissue transfer. | Laryngoscope | 2015 |
| 26332390 | The Risk Factors of Readmission in Postoperative Gynecologic Oncology Patients at a Single Institution. | Int J Gynecol Cancer | 2015 |
| 26392296 | Defining the effects of age and gender on immune response and outcomes to melanoma vaccination: a retrospective analysis of a single-institution clinical trials' experience. | Cancer Immunol Immunother | 2015 |
| 25567000 | Tubular carcinoma of the breast: institutional and SEER database analysis supporting a unique classification. | Breast Dis | 2015 |
| 24756419 | Immunologic hierarchy, class II MHC promiscuity, and epitope spreading of a melanoma helper peptide vaccine. | Cancer Immunol Immunother | 2014 |
| 25038848 | Effect of neoadjuvant temozolomide upon volume reduction and resection of diffuse low-grade glioma. | J Neurooncol | 2014 |
| 25126421 | A melanoma helper peptide vaccine increases Th1 cytokine production by leukocytes in peripheral blood and immunized lymph nodes. | J Immunother Cancer | 2014 |
| 24841355 | Inflammatory adverse events are associated with disease-free survival after vaccine therapy among patients with melanoma. | Ann Surg Oncol | 2014 |
| 23043862 | Infrared thermography of cutaneous melanoma metastases. | J Surg Res | 2013 |
| 23657629 | Activation, dysfunction and retention of T cells in vaccine sites after injection of incomplete Freund's adjuvant, with or without peptide. | Cancer Immunol Immunother | 2013 |
| 23620404 | Clinical activity and safety of combination therapy with temsirolimus and bevacizumab for advanced melanoma: a phase II trial (CTEP 7190/Mel47). | Clin Cancer Res | 2013 |
| 23712611 | Factors related to decision making and substance use in adolescent survivors of childhood cancer: a presenting clinical profile. | J Cancer Surviv | 2013 |
| 23357887 | A substance use decision aid for medically at-risk adolescents: results of a randomized controlled trial for cancer-surviving adolescents. | Cancer Nurs | 2013 |
| 22266112 | Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma. | Cancer Res | 2012 |
| 24331594 | Predictors of retention and BMI loss or stabilization in obese youth enrolled in a weight loss intervention. | Obes Res Clin Pract | 2012 |
| 23181148 | Predictors of Retention and BMI Loss or Stabilization in Obese Youth Enrolled in a Weight Loss Intervention. | Obes Res Clin Pract | 2012 |
| 22910692 | Beyond mere obesity: effect of increasing obesity classifications on hysterectomy outcomes for uterine cancer/hyperplasia. | Gynecol Oncol | 2012 |